Health Care Weekly: Hims Defends Cancellation Policies; Comer Probes PBM Audits of Independent Pharmacies; Baxter Warned on Sterility Issues; Beta Bionics Pulls Application for Next-Gen Dosing Algorithm; FDA Targets ‘Gray or Black’ Peptide Market; CMS Eyes Premium Tax Credit Rule; Corcept, Genmab Tout Cancer Wins

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • Hims says cancelling service is easier than signing up in motion to dismiss. • Congress scrutinizes ‘Big Three’ PBMs’ audits of independent pharmacies. • […]